Skip to content

Clinical trials

Phase 2 Thrombocytopenia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Phase: Phase 2 Country / region: China Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20191
20201
20215
20223
20234
20241
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Unknown status8
Completed4
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University People's Hospital3
Institute of Hematology & Blood Diseases Hospital, China2
Shandong University2
The First Affiliated Hospital of Soochow University2
Anhui Provincial Hospital1
Beijing Hospital1
Fudan University1
JIANYANG WANG1
Peking Union Medical College Hospital1
Peking University Cancer Hospital & Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia22
Antiphospholipid Syndrome2
Pathologic Complete Response2
Radiation Injuries2
Uterine Cervical Neoplasms2
Blood Coagulation Disorders1
Blood Platelet Disorders1
Breast Neoplasms1
Carcinoma, Hepatocellular1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.